Interpreting the Clinical Significance of Spleen Stiffness in Baveno VII Risk Stratification [0.03%]
BavenoⅦ风险 stratification中脾硬度的临床意义解读
Yuanyuan Yang
Yuanyuan Yang
Response to Letter to the Editor 'Key Considerations to Broaden the Validity of HCV-Related LC/CLD Mortality Research in Taiwan' [0.03%]
来信「扩大台湾丙型肝炎相关肝硬化/慢性肝病死亡研究有效性的关键考虑因素」的回应
Cheng-Yeh Yang,Chun-Yen Lin,Rong-Nan Chien et al.
Cheng-Yeh Yang et al.
From Creatinine Cut-Offs to Bedside Precision: A Road-Map for Safer Terlipressin in Early Hepatorenal Syndrome [0.03%]
从肌酐截断值到床边精准医学：早期肝肾综合征更安全使用特昔普生的路线图
Zuomin Wang,Qinwei Liu,Wangdong Deng
Zuomin Wang
Author Response to Letter to the Editor: Tofacitinib as a Steroid-Free Induction in Autoimmune Hepatitis: An Initial Experience [0.03%]
托法替尼治疗自身免疫性肝炎无类固醇诱导作用的初步研究——对《致编辑信件》的回复
Ellina Lytvyak,Gideon Hirschfield,Devika Shreekumar et al.
Ellina Lytvyak et al.
Letter to the Editor: Rethinking Myeloperoxidase Inhibition in MASH-Lessons From the COSMOS Trial [0.03%]
读者来信：反思MASH之外的髓过氧化物酶抑制——来自COSMOS试验的启示
Weixiong Zhu,Wancheng Li,Yuanhui Su et al.
Weixiong Zhu et al.
Increasing Prevalence of Steatotic Liver Disease in a Japanese Health Checkup Population, 2004-2022 [0.03%]
日本人群2004-2022年肝脂肪变性疾病患病率增加——基于健康体检结果分析
Yuki Nakahata,Takao Miwa,Akihiro Obora et al.
Yuki Nakahata et al.
Background and aims: Steatotic liver disease (SLD) affects more than 30% of the global population; however, trends in its prevalence remain poorly understood. This study aimed to elucidate prevalence trends of metabolic d...
Relevance of the Diagnostic Criteria for Diastolic Dysfunction in Patients With Transjugular Intrahepatic Portosystemic Shunt [0.03%]
诊断肝硬化患者经颈静脉肝内门体分流术适应证的标准价值研究
Elena Motto,Chiara Becchetti,Giovanni Perricone et al.
Elena Motto et al.
Background & aims: Cirrhotic cardiomyopathy (CCM), particularly diastolic dysfunction (DD), often remains silent until stress occurs. Transjugular intrahepatic portosystemic shunt (TIPS) may unmask DD due to hemodynamic s...
Reply to "Methodological Considerations on Early Hemostatic Treatment for Spontaneous Rupture of HCC" [0.03%]
对“肝癌破裂早期止血治疗的几点商榷”的回复
Apolline Commin,Chloé Metivier,Rémy Morello et al.
Apolline Commin et al.
Enhanced Functionality of Anti-GPC3 CAR-T Cells Against Hepatocellular Carcinoma Through Locoregional Administration [0.03%]
局部注射增强GPC3靶向的CAR-T细胞治疗肝癌的功效
Jue Wang,Jiale Qiu,Kin Ching Tsang et al.
Jue Wang et al.
Background & aims: The prognosis for patients with hepatocellular carcinoma (HCC) remains suboptimal, despite the rapid advancement of anti-cancer immunotherapy. Chimeric antigen receptor (CAR) T cell therapy targeting gl...